Square Pharma's Q2 profit rises on higher sales, subsidiary income
Square Pharmaceuticals posted double-digit year-on-year profit growth to Tk 7.27 billion in the second quarter of FY26, fueled by higher sales and substantial income from subsidiaries. The 10 per cent year-on-year growth in earnings in the October-December quarter of FY26 pushed up the EPS of the
